1.A Criteria for Calculation of Hospital Rate for the Health Insurance.
Journal of the Korean Pediatric Society 1989;32(4):590-
No abstract available.
Insurance, Health*
2.A Criteria for Calculation of Hospital Rate for the Health Insurance(53).
Journal of the Korean Pediatric Society 1990;33(10):1462-1463
No abstract available.
3.A Criteria for Calculation of Hospital Rate for the Health Insurance.
Journal of the Korean Pediatric Society 1989;32(5):742-
No abstract available.
Insurance, Health*
4.A Criteria for Calculation of Hospital rate for the Health Insurance.
Journal of the Korean Pediatric Society 1989;32(2):298-
No abstract available.
Insurance, Health*
5.A Criteria for Calculation of Hospital rate for the Health Insurance.
Journal of the Korean Pediatric Society 1989;32(2):298-
No abstract available.
Insurance, Health*
6.A Criteria for Calculation of Hospital Rate for the Health Insurance.
Journal of the Korean Pediatric Society 1989;32(6):878-
No abstract available.
Insurance, Health*
7.A Criteria for Calculation of Hospital Rate for the Health Insurance.
Journal of the Korean Pediatric Society 1989;32(6):878-
No abstract available.
Insurance, Health*
8.A Criteria for Calculation of Hospital Rate for the Health Insurance (56).
Journal of the Korean Pediatric Society 1990;33(12):1750-
No abstract available.
Insurance, Health*
9.A Case of Acute Lymphocytic Leukemia with Both Renal Enlargement.
Choong Kil CHUNG ; Jae Seung LEE ; Byung Soo KIM
Journal of the Korean Pediatric Society 1981;24(5):502-504
A case of acute lymphocytic leukemia with both renal enlargement found in a 2 3/12-year-old female has been presented. A brief review of the literatures was made on this subject.
Female
;
Humans
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
10.Clinical Trials of Tavegyl in Dermatologic Field.
Choong Sang KIM ; Jai Il YOUN ; Yoo Shin LEE ; Soon Bok LEE ; Yang Ja PARK ; Dong Kil BYUN ; Won HOUH
Korean Journal of Dermatology 1974;12(2):33-37
Clinical trials were done to obtain ifnormation on the clinical efficacy, tolerance and side effects of a new antihistarnine, Mecloprodine(Tavegyl), in various skin disordetrs. A total of 48 patients suffered from various skin disorders as urticaria, eczema etc. v ere treated with 2mg. daily for 3 days to 15 days according to state of disorders. The results are as follows. 1. Improvement was noticed in 79.2% of total patients(38/48). 2. Tavegyl was efiective in all 8 cases of acute urticaria and most cases(7/8) of urticaria factitia. 3. Among 19 cases of chronic urticaria, improvement was noticed in 13 cases(68. 49). Improvement was alsa noticed in all 6 cases of eczema. 5. Drowsiness and weakness cccurred in 6.2% of cases(3/48).
Clemastine*
;
Eczema
;
Humans
;
Skin
;
Sleep Stages
;
Urticaria
Result Analysis
Print
Save
E-mail